Search research articles
Contact Us
Filters
Showing results (71-80 of 95) with videos related to
Page
of 10
Sort By:
NPJ Vaccines
|
October 30, 2024
High protection and transmission-blocking immunity elicited by single-cycle SARS-CoV-2 vaccine in hamsters
Martin Joseph Lett, Fabian Otte, David Hauser, et al.
Virus Evolution
|
September 25, 2023
Continuous presence of genetically diverse rustrela virus lineages in yellow-necked field mouse reservoir populations in northeastern Germany
Sina Nippert, Dennis Rubbenstroth, Jessica Anna Geers, et al.
Emerging Infectious Diseases
|
May 19, 2018
Occupation-Associated Fatal Limbic Encephalitis Caused by Variegated Squirrel Bornavirus 1, Germany, 2013
Dennis Tappe, Kore Schlottau, Daniel Cadar, et al.
Nature Communications
|
February 13, 2023
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
Björn Corleis, Donata Hoffmann, Susanne Rauch, et al.
Emerging Microbes & Infections
|
March 12, 2021
Introduction and spread of variegated squirrel bornavirus 1 (VSBV-1) between exotic squirrels and spill-over infections to humans in Germany
Daniel Cadar, Valerie Allendorf, Vanessa Schulze, et al.
One Health (Amsterdam, Netherlands)
|
August 30, 2021
Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test
Carmen W E Embregts, Babs Verstrepen, Jan A M Langermans, et al.
Emerging Infectious Diseases
|
June 21, 2021
Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement Home
Claudia Schulz, Claudia Wylezich, Kerstin Wernike, et al.
Nature Microbiology
|
September 19, 2019
Bat influenza viruses transmit among bats but are poorly adapted to non-bat species
Kevin Ciminski, Wei Ran, Marco Gorka, et al.
Emerging Infectious Diseases
|
February 22, 2017
Variegated Squirrel Bornavirus 1 in Squirrels, Germany and the Netherlands
Kore Schlottau, Maria Jenckel, Judith van den Brand, et al.
Nature Communications
|
July 1, 2021
CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2
Donata Hoffmann, Björn Corleis, Susanne Rauch, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 95) with videos related to
Sort By:
Page
of 10
NPJ Vaccines
|
October 30, 2024
High protection and transmission-blocking immunity elicited by single-cycle SARS-CoV-2 vaccine in hamsters
Martin Joseph Lett, Fabian Otte, David Hauser, et al.
Virus Evolution
|
September 25, 2023
Continuous presence of genetically diverse rustrela virus lineages in yellow-necked field mouse reservoir populations in northeastern Germany
Sina Nippert, Dennis Rubbenstroth, Jessica Anna Geers, et al.
Emerging Infectious Diseases
|
May 19, 2018
Occupation-Associated Fatal Limbic Encephalitis Caused by Variegated Squirrel Bornavirus 1, Germany, 2013
Dennis Tappe, Kore Schlottau, Daniel Cadar, et al.
Nature Communications
|
February 13, 2023
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
Björn Corleis, Donata Hoffmann, Susanne Rauch, et al.
Emerging Microbes & Infections
|
March 12, 2021
Introduction and spread of variegated squirrel bornavirus 1 (VSBV-1) between exotic squirrels and spill-over infections to humans in Germany
Daniel Cadar, Valerie Allendorf, Vanessa Schulze, et al.
One Health (Amsterdam, Netherlands)
|
August 30, 2021
Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test
Carmen W E Embregts, Babs Verstrepen, Jan A M Langermans, et al.
Emerging Infectious Diseases
|
June 21, 2021
Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement Home
Claudia Schulz, Claudia Wylezich, Kerstin Wernike, et al.
Nature Microbiology
|
September 19, 2019
Bat influenza viruses transmit among bats but are poorly adapted to non-bat species
Kevin Ciminski, Wei Ran, Marco Gorka, et al.
Emerging Infectious Diseases
|
February 22, 2017
Variegated Squirrel Bornavirus 1 in Squirrels, Germany and the Netherlands
Kore Schlottau, Maria Jenckel, Judith van den Brand, et al.
Nature Communications
|
July 1, 2021
CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2
Donata Hoffmann, Björn Corleis, Susanne Rauch, et al.
Page
of 10